Advertisement
Canada markets open in 6 hours 57 minutes

  • S&P/TSX

    22,244.02
    +20.35 (+0.09%)
     

  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     

  • DOW

    39,308.00
    -23.90 (-0.06%)
     

  • CAD/USD

    0.7349
    +0.0003 (+0.04%)
     

  • CRUDE OIL

    83.72
    -0.16 (-0.19%)
     

  • Bitcoin CAD

    73,737.72
    -6,033.43 (-7.56%)
     

  • CMC Crypto 200

    1,130.57
    -78.13 (-6.46%)
     

  • GOLD FUTURES

    2,373.50
    +4.10 (+0.17%)
     

  • RUSSELL 2000

    2,036.62
    +2.75 (+0.14%)
     

  • 10-Yr Bond

    4.3550
    0.0000 (0.00%)
     

  • NASDAQ futures

    20,442.75
    +31.25 (+0.15%)
     

  • VOLATILITY

    12.26
    +0.17 (+1.41%)
     

  • FTSE

    8,241.26
    +70.14 (+0.86%)
     

  • NIKKEI 225

    40,912.37
    -1.28 (-0.00%)
     

  • CAD/EUR

    0.6788
    -0.0004 (-0.06%)
     

Clarivate PLC (CLVT) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks Equity Research
·2 min read

Clarivate PLC (CLVT) reported $668.8 million in revenue for the quarter ended June 2023, representing a year-over-year decline of 2.6%. EPS of $0.21 for the same period compares to $0.22 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $675.47 million, representing a surprise of -0.99%. The company delivered an EPS surprise of +10.53%, with the consensus EPS estimate being $0.19.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Clarivate PLC performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Annualized Contract Value (ACV): $1.57 billion compared to the $1.61 billion average estimate based on two analysts.

  • Revenue- Intellectual Property: $216.30 million versus $217.51 million estimated by three analysts on average.

  • Revenue- Life Sciences and Healthcare: $110.50 million versus the three-analyst average estimate of $115.99 million.

  • Revenue- Re-occurring revenues: $111 million compared to the $116.46 million average estimate based on two analysts.

  • Revenue- Academia and Government: $342 million versus the two-analyst average estimate of $338.03 million.

  • Revenue- Subscription Revenue: $406 million versus $416.77 million estimated by two analysts on average.

View all Key Company Metrics for Clarivate PLC here>>>

Shares of Clarivate PLC have returned -5.5% over the past month versus the Zacks S&P 500 composite's +1.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Clarivate PLC (CLVT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research